BNBX
Applied DNA Sciences, Inc.
NASDAQ: BNBX · FINANCIAL SERVICES · ASSET MANAGEMENT
$0.53
+3.91% today
Updated 2026-04-30
Market cap
$2.93M
P/E ratio
0.00
P/S ratio
1.60x
EPS (TTM)
$282.39
Dividend yield
—
52W range
$0 – $14
Volume
1.0M
Applied DNA Sciences, Inc. (BNBX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating cash flow | $-13.39M | $-8.98M | $-6.22M | $-13.71M | $-12.52M |
| Capital expenditures | $2.55M | $489553.00 | $78448.00 | $407904.00 | $313121.00 |
| Depreciation | — | — | — | — | — |
| Stock-based comp | $1.67M | $2.52M | $1.03M | $572293.00 | $102021.00 |
| Free cash flow | $-15.94M | $-9.47M | $-6.30M | $-14.12M | $-12.83M |
| Investing cash flow | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — |
| Dividends paid | — | — | — | — | — |
| Share repurchases | — | — | — | — | — |
| Debt repayment | — | — | — | — | — |
| Net change in cash | — | — | — | — | — |